A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

NCT02344355 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Temozolomide
RADIATION: radiation therapy
DRUG: Ascorbic Acid

Sponsor

Bryan Allen

Collaborators

Holden Comprehensive Cancer Center
National Cancer Institute (NCI)
Gateway for Cancer Research